VRTX · Categories · Coverage
VRTX - Analyst coverage initiated
Vertex Pharmaceuticals Incorporated (VRTX) analyst coverage initiated - real-time wire coverage filtered to Coverage only.
Recent Coverage for VRTX
- Jefferies initiated coverage on Vertex Pharma with a new price targetJefferies initiated coverage of Vertex Pharma with a rating of Buy and set a new price target of $580.00
- Scotiabank initiated coverage on Vertex Pharma with a new price targetScotiabank initiated coverage of Vertex Pharma with a rating of Sector Outperform and set a new price target of $495.00
- Raymond James initiated coverage on Vertex PharmaRaymond James initiated coverage of Vertex Pharma with a rating of Mkt Perform
- Citigroup initiated coverage on Vertex Pharma with a new price targetCitigroup initiated coverage of Vertex Pharma with a rating of Buy and set a new price target of $575.00
- Scotiabank initiated coverage on Vertex PharmaScotiabank initiated coverage of Vertex Pharma with a rating of Sector Perform
- Redburn Atlantic initiated coverage on Vertex Pharma with a new price targetRedburn Atlantic initiated coverage of Vertex Pharma with a rating of Buy and set a new price target of $545.00
- Wolfe Research initiated coverage on Vertex Pharma with a new price targetWolfe Research initiated coverage of Vertex Pharma with a rating of Outperform and set a new price target of $515.00
- William Blair initiated coverage on Vertex Pharma with a new price targetWilliam Blair initiated coverage of Vertex Pharma with a rating of Outperform and set a new price target of $382.00
- Bernstein initiated coverage on Vertex Pharma with a new price targetBernstein initiated coverage of Vertex Pharma with a rating of Outperform and set a new price target of $344.00
- Canaccord Genuity initiated coverage on Vertex Pharma with a new price targetCanaccord Genuity initiated coverage of Vertex Pharma with a rating of Hold and set a new price target of $311.00
- Cantor Fitzgerald initiated coverage on Vertex Pharma with a new price targetCantor Fitzgerald initiated coverage of Vertex Pharma with a rating of Overweight and set a new price target of $365.00
- SVB Leerink initiated coverage on Vertex Pharma with a new price targetSVB Leerink initiated coverage of Vertex Pharma with a rating of Mkt Perform and set a new price target of $265.00
- Wells Fargo initiated coverage on Vertex Pharma with a new price targetWells Fargo initiated coverage of Vertex Pharma with a rating of Overweight and set a new price target of $270.00
- BMO Capital initiated coverage on Vertex Pharmaceuticals with a new price targetBMO Capital initiated coverage of Vertex Pharmaceuticals with a rating of Market Perform and set a new price target of $202.00
- Raymond James initiated coverage on Vertex PharmaceuticalsRaymond James initiated coverage of Vertex Pharmaceuticals with a rating of Market Perform